Pentoxifylline Does Not Decrease Short-term Mortality but Does Reduce Complications in Patients With Advanced Cirrhosis
Open Access
- 1 May 2010
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 138 (5) , 1755-1762.e2
Abstract
No abstract availableKeywords
Funding Information
- Ministère des Affaires Sociales et de la Santé
This publication has 35 references indexed in Scilit:
- A Randomized, Double-Blinded, Placebo-Controlled Multicenter Trial of Etanercept in the Treatment of Alcoholic HepatitisGastroenterology, 2008
- In vivo altered unfolded protein response and apoptosis in livers from lipopolysaccharide-challenged cirrhotic ratsJournal of Hepatology, 2007
- Upregulation of TNF-alpha production signaling pathways in monocytes from patients with advanced cirrhosis: Possible role of Akt and IRAK-MJournal of Hepatology, 2006
- 36 Pentoxifylline prevents small intestinal bacterial overgrowth (SIBO), bacterial translocation (BT) and spontaneous bacterial peritonitis (SBP) in experimental cirrhosisJournal of Hepatology, 2004
- Soluble TNF-R1, but not tumor necrosis factor alpha, predicts the 3-month mortality in patients with alcoholic hepatitisJournal of Hepatology, 2004
- Points of control in inflammationNature, 2002
- Short–Term Prognosis in Critically Ill Patients With Cirrhosis Assessed by Prognostic Scoring SystemsHepatology, 2001
- A Model to Predict Survival in Patients With End–Stage Liver DiseaseHepatology, 2001
- Cytokines and the liverJournal of Hepatology, 1997
- Plasma Tumor Necrosis Factor α Predicts Decreased Long‐Term Survival in Severe Alcoholic HepatitisAlcohol, Clinical and Experimental Research, 1990